Literature DB >> 19760303

Evaluation and treatment of superficial esophageal cancer.

Steven R DeMeester1.   

Abstract

INTRODUCTION: Adenocarcinoma of the esophagus is the fastest increasing cancer in the USA, and an increasing number of patients are identified with early-stage disease. The evaluation and treatment of these superficial cancers differs from local and regionally advanced lesions.
METHODS: This paper is a review of the current methods to diagnose, stage, and treat superficial esophageal adenocarcinoma.
RESULTS: Intramucosal adenocarcinoma can be effectively treated with endoscopic resection techniques and with less morbid surgical options including a vagal-sparing esophagectomy. However, submucosal lesions are associated with a significant risk for lymph node metastases and are best treated with esophagectomy and lymphadenectomy. DISCUSSION: There has been a major shift in the treatment for Barrett's high-grade dysplasia and superficial esophageal adenocarcinoma in the past 10 years. New therapies minimize the morbidity and mortality of traditional forms of esophagectomy and in some cases allow esophageal preservation. Individualization of therapy will allow maximization of successful outcome and quality of life with minimization of complications and recurrence of Barrett's or cancer.

Entities:  

Mesh:

Year:  2009        PMID: 19760303     DOI: 10.1007/s11605-009-1025-1

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  40 in total

1.  Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett's esophagus.

Authors:  C Ell; A May; L Gossner; O Pech; E Günter; G Mayer; R Henrich; M Vieth; H Müller; G Seitz; M Stolte
Journal:  Gastroenterology       Date:  2000-04       Impact factor: 22.682

2.  The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence.

Authors:  Heiko Pohl; H Gilbert Welch
Journal:  J Natl Cancer Inst       Date:  2005-01-19       Impact factor: 13.506

3.  Superficial adenocarcinoma of the esophagus.

Authors:  T W Rice; E H Blackstone; J R Goldblum; M M DeCamp; S C Murthy; G W Falk; A H Ormsby; L A Rybicki; J E Richter; D J Adelstein
Journal:  J Thorac Cardiovasc Surg       Date:  2001-12       Impact factor: 5.209

4.  Esophageal stripping with preservation of the vagus nerve.

Authors:  H Akiyama; M Tsurumaru; T Kawamura; Y Ono
Journal:  Int Surg       Date:  1982 Apr-Jun

5.  Occult esophageal adenocarcinoma: extent of disease and implications for effective therapy.

Authors:  J J Nigro; J A Hagen; T R DeMeester; S R DeMeester; J Theisen; J H Peters; M Kiyabu
Journal:  Ann Surg       Date:  1999-09       Impact factor: 12.969

6.  Clinical biology and surgical therapy of intramucosal adenocarcinoma of the esophagus.

Authors:  Daniel S Oh; Jeffrey A Hagen; Parakrama T Chandrasoma; Christy M Dunst; Steven R Demeester; Mohammad Alavi; Cedric G Bremner; John Lipham; Christian Rizzetto; Richard Cote; Tom R Demeester
Journal:  J Am Coll Surg       Date:  2006-06-22       Impact factor: 6.113

7.  Pilot series of radiofrequency ablation of Barrett's esophagus with or without neoplasia.

Authors:  J C Hernandez; S Reicher; D Chung; B V Pham; F Tsai; G Disibio; S French; V E Eysselein
Journal:  Endoscopy       Date:  2008-05       Impact factor: 10.093

8.  Early Barrett's carcinoma with "low-risk" submucosal invasion: long-term results of endoscopic resection with a curative intent.

Authors:  Hendrik Manner; Andrea May; Oliver Pech; Liebwin Gossner; Thomas Rabenstein; Erwin Günter; Michael Vieth; Manfred Stolte; Christian Ell
Journal:  Am J Gastroenterol       Date:  2008-09-10       Impact factor: 10.864

9.  Esophagectomy for high grade dysplasia is safe, curative, and results in good alimentary outcome.

Authors:  Valerie A Williams; Thomas J Watson; Fernando A Herbella; Oliver Gellersen; Daniel Raymond; Carolyn Jones; Jeffrey H Peters
Journal:  J Gastrointest Surg       Date:  2007-10-02       Impact factor: 3.452

10.  Nutritional stimulation of cholecystokinin receptors inhibits inflammation via the vagus nerve.

Authors:  Misha D Luyer; Jan Willem M Greve; M'hamed Hadfoune; Jan A Jacobs; Cornelis H Dejong; Wim A Buurman
Journal:  J Exp Med       Date:  2005-10-10       Impact factor: 14.307

View more
  12 in total

1.  Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process.

Authors:  Cathy Bennett; Nimish Vakil; Jacques Bergman; Rebecca Harrison; Robert Odze; Michael Vieth; Scott Sanders; Laura Gay; Oliver Pech; Gaius Longcroft-Wheaton; Yvonne Romero; John Inadomi; Jan Tack; Douglas A Corley; Hendrik Manner; Susi Green; David Al Dulaimi; Haythem Ali; Bill Allum; Mark Anderson; Howard Curtis; Gary Falk; M Brian Fennerty; Grant Fullarton; Kausilia Krishnadath; Stephen J Meltzer; David Armstrong; Robert Ganz; Gianpaolo Cengia; James J Going; John Goldblum; Charles Gordon; Heike Grabsch; Chris Haigh; Michio Hongo; David Johnston; Ricky Forbes-Young; Elaine Kay; Philip Kaye; Toni Lerut; Laurence B Lovat; Lars Lundell; Philip Mairs; Tadakuza Shimoda; Stuart Spechler; Stephen Sontag; Peter Malfertheiner; Iain Murray; Manoj Nanji; David Poller; Krish Ragunath; Jaroslaw Regula; Renzo Cestari; Neil Shepherd; Rajvinder Singh; Hubert J Stein; Nicholas J Talley; Jean-Paul Galmiche; Tony C K Tham; Peter Watson; Lisa Yerian; Massimo Rugge; Thomas W Rice; John Hart; Stuart Gittens; David Hewin; Juergen Hochberger; Peter Kahrilas; Sean Preston; Richard Sampliner; Prateek Sharma; Robert Stuart; Kenneth Wang; Irving Waxman; Chris Abley; Duncan Loft; Ian Penman; Nicholas J Shaheen; Amitabh Chak; Gareth Davies; Lorna Dunn; Yngve Falck-Ytter; John Decaestecker; Pradeep Bhandari; Christian Ell; S Michael Griffin; Stephen Attwood; Hugh Barr; John Allen; Mark K Ferguson; Paul Moayyedi; Janusz A Z Jankowski
Journal:  Gastroenterology       Date:  2012-04-24       Impact factor: 22.682

2.  Management of Esophageal Cancer.

Authors:  Steven R DeMeester
Journal:  Gastroenterol Hepatol (N Y)       Date:  2014-08

Review 3.  The impact of flexible endoscopy in esophageal surgery.

Authors:  Alejandro Nieponice; Fabio Nachman; Adolfo Badaloni; Franco Ciotola; Cecilia Zubieta; Mauricio Ramirez
Journal:  J Thorac Dis       Date:  2017-07       Impact factor: 2.895

Review 4.  Emerging Concepts for the Endoscopic Management of Superficial Esophageal Adenocarcinoma.

Authors:  Christina L Greene; Stephanie G Worrell; Stephen E Attwood; Parakrama Chandrasoma; Kenneth Chang; Tom R DeMeester; Reginald V Lord; Elizabeth Montgomery; Oliver Pech; John Vallone; Michael Vieth; Kenneth K Wang; Steven R DeMeester
Journal:  J Gastrointest Surg       Date:  2015-12-21       Impact factor: 3.452

5.  DNA methylation as an adjunct to histopathology to detect prevalent, inconspicuous dysplasia and early-stage neoplasia in Barrett's esophagus.

Authors:  Muhammad A Alvi; Xinxue Liu; Maria O'Donovan; Richard Newton; Lorenz Wernisch; Nicholas B Shannon; Kareem Shariff; Massimiliano di Pietro; Jacques J G H M Bergman; Krish Ragunath; Rebecca C Fitzgerald
Journal:  Clin Cancer Res       Date:  2012-12-14       Impact factor: 12.531

6.  Can the Risk of Lymph Node Metastases Be Gauged in Endoscopically Resected Submucosal Esophageal Adenocarcinomas? A Multi-Center Study.

Authors:  Joshua A Boys; Stephanie G Worrell; Parakrama Chandrasoma; John G Vallone; Dipen M Maru; Lizhi Zhang; Shanda H Blackmon; Karen J Dickinson; Christy M Dunst; Wayne L Hofstetter; Michael J Lada; Brian E Louie; Daniela Molena; Thomas J Watson; Steven R DeMeester
Journal:  J Gastrointest Surg       Date:  2015-09-25       Impact factor: 3.452

7.  Management of early-stage esophageal neoplasia (MESEN) consensus.

Authors:  Alejandro Nieponice; Adolfo E Badaloni; Blair A Jobe; Toshitaka Hoppo; Carlos Pellegrini; Vic Velanovich; Gary W Falk; Kevin Reavis; Lee Swanstrom; Virender K Sharma; Fabio Nachman; Franco F Ciotola; Luis E Caro; Cecilio Cerisoli; Demetrio Cavadas; Luis Durand Figueroa; Daniel Pirchi; Michael Gibson; Santiago Elizalde; Henry Cohen
Journal:  World J Surg       Date:  2014-01       Impact factor: 3.352

8.  Multidisciplinary treatment of T1a adenocarcinoma in Barrett's esophagus: contemporary comparison of endoscopic and surgical treatment in physiologically fit patients.

Authors:  Henner M Schmidt; Kamran Mohiuddin; Artur M Bodnar; Mustapha El Lakis; Stephen Kaplan; Shayan Irani; Ian Gan; Andrew Ross; Donald E Low
Journal:  Surg Endosc       Date:  2015-11-05       Impact factor: 4.584

Review 9.  Management strategies of Barrett's esophagus.

Authors:  Giovanni D De Palma
Journal:  World J Gastroenterol       Date:  2012-11-21       Impact factor: 5.742

Review 10.  Surgical Therapy of Early Carcinoma of the Esophagus.

Authors:  Michael Pauthner; Thomas Haist; Markus Mann; Dietmar Lorenz
Journal:  Viszeralmedizin       Date:  2015-10-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.